Axbio (安序源) Pre-IPO: Structural Challenges
China's Axbio plans to raise $100 million in Hong Kong. Our further look suggests that the company is facing challenges commercializing NMPA...
401 Views
Pre-IPO Axbio International - Has the Potential to Be a Game Changer in Molecular Testing Market
Axbio's innovative products and technology give them a competitive edge in the industry. Import substitution policy is expected to facilitate the...
342 Views
ECM Weekly (24 November 2025) - CATL, Hengrui, Hongqiao, WT Micro, SBI Shinsei, NS Group, Ultragreen
Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
496 Views
ECM Weekly (12 May 2025) - CATL, Hengrui, Ather, Drinda, Green Tea, Swiggy, Sagility, Niva Bupa
Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
663 Views
Axbio (安序源) Pre-IPO: First Take of the Deal
China's Axbio plans to raise $100 million in Hong Kong listing with CICC and SPDB as joint sponsors, but doubts remain on deal prospects after...
649 Views